BioSpace News Archive

Integra LifeSciences Holdings Corporation, a leading global medical technology company, announced that it will participate in two investor conferences in September.

KemPharm, Inc., a specialty pharmaceutical company engaged in the discovery and development of proprietary prodrugs, announced that its president and chief executive officer, Travis C.

CryoLife, Inc., a leading cardiac and vascular surgery company focused on aortic disease, announced that it has acquired Ascyrus Medical LLC.

Prognostic gene expression profile test for metastatic risk in cutaneous squamous cell carcinoma now available to clinicians in the U.S.

Ironwood Pharmaceuticals, Inc. will participate in fireside chats at two upcoming virtual investor conferences in September

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that John Sheridan, president and chief executive officer, will present a company update at the following virtual investor conferences:

Medpace Holdings, Inc. announced that it will report its third quarter 2020 financial results after the market close on Monday, October 26, 2020.

Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, is pleased to announce that on September 2, 2020 the Supreme Court of the State of New York, New York County (the “Court”) has dismissed with prejudice Platinum-Montaur Life Sciences LLC’s (“Platinum-Montaur”) law suit against the Company.

Scholar Rock (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming virtual investor conferences: Baird’s 2020 Global Healthcare Conference on Wednesday, September 9, 2020 at 3:10 pm ET. Citi’s 15 th Annual BioPharma Virtua

NVX-CoV2373 was generally well-tolerated and elicited robust antibody responses numerically superior to that seen in human convalescent sera